Salvinorin B

Salvinorin B
Clinical data
Other namesDivinorin B; Desacetyldivinorin A; Desacetylsalvinorin A; SB; SalB
ATC code
  • None
Identifiers
  • methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-2-(furan-3-yl)-9-hydroxy-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H26O7
Molar mass390.432 g·mol−1
3D model (JSmol)
  • C[C@@]12CC[C@H]3C(=O)O[C@@H](C[C@@]3([C@H]1C(=O)[C@H](C[C@H]2C(=O)OC)O)C)C4=COC=C4
  • InChI=1S/C21H26O7/c1-20-6-4-12-19(25)28-15(11-5-7-27-10-11)9-21(12,2)17(20)16(23)14(22)8-13(20)18(24)26-3/h5,7,10,12-15,17,22H,4,6,8-9H2,1-3H3/t12-,13-,14-,15-,17-,20-,21-/m0/s1
  • Key:BLTMVAIOAAGYAR-CEFSSPBYSA-N

Salvinorin B is a naturally occurring terpene of the salvinorin family and constituent of Salvia divinorum. In contrast to salvinorin A, salvinorin B is inactive at the κ-opioid receptor. Accordingly, unlike salvinorin A, salvinorin B is inactive in producing effects in rodents. Salvinorin B was first described in the scientific literature by Leander J. Valdes and colleagues by 1984. Although salvinorin B is inactive, two derivatives, salvinorin B methoxymethyl ether (2-MMSB) and salvinorin B ethoxymethyl ether (2-EMSB), are highly potent κ-opioid receptor agonists with greater activity than salvinorin A.